If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPXOG.L Regulatory News (PXOG)

  • There is currently no data for PXOG

Final Results

10 Jun 2016 07:00

RNS Number : 7996A
Prospex Oil and Gas PLC
10 June 2016
Β 

Prospex Oil and Gas plc

("Propsex" or the "Company")

Annual Results for the Twelve Months ended 31 December 2015

Chairman's Statement

2015 and the first part of 2016 was a transformational period for the Company. In April 2015, Prospex became an AIM investing company. Since April 2015, the new management team has reviewed over 20 projects and over the period the Company made several investments. The most significant investment to date is the acquisition of 49% of the shares of Hutton Poland which in turn holds the Kolo license.

Following extensive due diligence and assessment of geological data, the management team concluded that the Kolo license provides an attractive opportunity for the Company. This is borne out with the publication of the independent Competent Persons' Report ("CPR") on 26 May 2016 by AGR TRACS which included a gross best estimate for the Boleslaw prospect within the Kolo license at 87 bscf and a risked current valuation ranging from Β£5m to Β£8.4m (net to Prospex). This represents a significant premium over the Β£620,000 purchase price paid by the Company for the 49% interest in Hutton Poland, which completed in April 2016.

The CPR's economic results were used to interpolate indicative NPVs, these ranged from $44m to $95m (net to Prospex). The CPR modelled production scenarios at 3,333-6,666 boe per day from a single well. The directors believe that the anticipated well tests could give sufficient information that further appraisal may not be necessary and if so appraisal costs and the attendant shareholder dilution to fund them would be avoided.

Based on a successful Boleshaw well and the assumptions set out in the announcement dated 26 May 2016, the project could generate results in the upper end of the range the team is targeting. The directors believe the current state of the world energy market provides opportunities for the Company to make other investments at critical stages in a project's life cycle which could provide significant and tangible results for the Company's shareholders in a relatively short time frame.

As announced on 26 May 2016, a well on the Boleslaw prospect is planned for the 4th quarter 2016. The Company's Β£1.6 million equity raise in May 2016 includes Prospex's share of the funding for this well.

The management team and Board are actively seeking additional investment opportunities.

On behalf of the Board I would like to thank Gavin Burnell for the significant contribution he made during his term as a director. Our thanks also go to the advisors and service providers who were and continue to be instrumental in this transformational phase.

Dispatch of Report and Accounts and Notice of AGM

Copies of the Annual Report and Accounts are expected to be posted to shareholders on 16 June and have been posted on the Company's website (www.prospexoilandgas.com) with effect from today. The Annual Report and Accounts includes a copy of the Notice of Annual General Meeting which convenes the Company's Annual General Meeting at 9am on 14 July at Peterhouse Corporate Finance Limited, 3rd Floor, New Liverpool House, 15 Eldon Street, London, EC2M 7LD.

Directors Subscription

Following the publication of the annual accounts, the directors confirm their intention to subscribe for up to Β£100,000 of Ordinary Shares in the Company at a price of 1p per Ordinary Shares, being the price of the placing announced on 26 May 2016. A further announcement, will be made shortly.

Enquiries

Prospex Oil and Gas plc

Β 

Edward Dawson, Managing Director

0207 887 1461

Β 

Β 

WH Ireland Limited (Nominated Adviser and Broker)

Β 

Katy Mitchell/Nick Prowting

Jay Ashfield

0113 394 6600

0207 220 1658

Β 

Β 

Peterhouse Corporate Finance Limited (Joint Broker)

Β 

Lucy Williams / Charles Goodfellow / Eran Zucker

0207 469 0932

Β 

Beaufort Securities Limited (Joint Broker)

Jon Belliss

Β 

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

FOR THE YEAR ENDED 31 DECEMBER 2015

2015

2014

Β 

Notes

Β£

Β£

Β 

Β 

Β 

Continuing operations

Β 

Administrative expenses

(601,892)

(452,056)

Β 

────────

────────

Β 

Operating loss

4

(601,892)

(452,056)

Β 

Β 

Surplus as a result of the CVA

98,885Β 

-Β 

Β 

────────

────────

Β 

(503,007)

(452,056)

Β 

Β 

Finance income

5

162Β 

34Β 

Β 

Fair value loss on derivative financial assets

14

-Β 

(168,188)

Β 

Finance expense

6

-Β 

(67,491)

Β 

────────

────────

Β 

Loss before income taxation

(502,845)

(687,701)

Β 

Β 

Income tax expense

7

411Β 

-Β 

Β 

────────

────────

Β 

Loss on ordinary activities after taxation from continuing operations

(502,434)

(687,701)

Β 

Β 

Discontinued operations

Β 

Profit/(loss) for the year from discontinued operations

11

571,745Β 

(3,892,744)

Β 

────────

────────

Β 

Profit/(loss) for the year

69,311Β 

(4,580,445)

Β 

Β 

Β 

Non-controlling interests

-Β 

771,232Β 

Β 

────────

────────

Β 

Profit/(loss) for the year and total comprehensive income attributable to owners of the parent

69,311Β 

(3,809,213)

Β 

════════

════════

Β 

Β 

Earnings/(loss) per share - basic and diluted

8

Β 

From continuing operations

(1.64)p

(12.63)p

Β 

From discontinued operations

1.86p

(57.33)p

Β 

════════

════════

Β 

Β 

The notes on pages 17 - 42 form an integral part of these financial statements.

Β 

Β 

Β 

Β 

Β 

Β 

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

AS AT 31 DECEMBER 2015

2015

2014

Β 

Notes

Β£

Β£

Β 

ASSETS

Β 

Non current assets

Β 

Tangible assets

9

1,274Β 

10,355Β 

Β 

Derivative financial assets

14

-Β 

-Β 

Β 

─────────

─────────

Β 

1,274Β 

10,355Β 

Β 

Β 

Current assets

Β 

Inventories

12

-Β 

977Β 

Β 

Trade and other receivables

13

155,909Β 

33,928Β 

Β 

Derivative financial assets

14

-Β 

46,359Β 

Β 

Cash and cash equivalents

15

382,216Β 

22,734Β 

Β 

─────────

─────────

Β 

538,125Β 

103,998Β 

Β 

Β 

LIABILITIES

Β 

Current liabilities

Β 

Trade and other payables

16

(80,875)

(365,873)

Β 

Borrowings

17

-Β 

(479,784)

Β 

─────────

─────────

Β 

Net current assets/(liabilities)

457,250Β 

(741,659)

Β 

─────────

─────────

Β 

Net assets/(liabilities)

458,524Β 

(731,304)

Β 

═════════

═════════

Β 

Β 

EQUITY

Β 

Share capital

20

2,657,234Β 

2,304,398Β 

Β 

Share premium account

6,732,714Β 

6,063,208Β 

Β 

Equity component - convertible loan note

-Β 

100,216Β 

Β 

Capital redemption reserve

43,333Β 

43,333Β 

Β 

Merger reserve

2,416,667Β 

2,416,667Β 

Β 

Profit and loss account

(11,391,424)

(11,531,728)

Β 

Foreign currency reserve

-Β 

39,467Β 

Β 

─────────

─────────

Β 

458,524Β 

(564,439)

Β 

Non-controlling interests

-Β 

(166,865)

Β 

─────────

─────────

Β 

Total equity/(deficit)

458,524Β 

(731,304)

Β 

═════════

═════════

Β 

Β 

Approved by the Board and authorised for issue on .........................

Β 

Β 

..............................

..............................

Β 

Edward Dawson

William Smith

Β 

Director

Director

Β 

Β 

Company Registration No. 03896382

Β 

Β 

The notes on pages 17 - 42 form an integral part of these financial statements.

Β 

Β 

Β 

Β 

COMPANY STATEMENT OF FINANCIAL POSITION

AS AT 31 DECEMBER 2015

Β 

2015

2014

Β 

Notes

Β£

Β£

Β£

Β£

Β 

ASSETS

Β 

Non current assets

Β 

Tangible assets

9

1,274Β 

-Β 

Β 

Investments

10

100Β 

-Β 

Β 

Derivative financial assets

14

-Β 

-Β 

Β 

─────────

─────────

Β 

1,374Β 

-Β 

Β 

Β 

Current assets

Β 

Trade and other receivables

13

155,909Β 

25,357Β 

Β 

Derivative financial assets

14

-Β 

46,359Β 

Β 

Cash and cash equivalents

15

382,216Β 

22,487Β 

Β 

─────────

─────────

Β 

538,125Β 

94,203Β 

Β 

Β 

LIABILITIES

Β 

Current liabilities

Β 

Trade and other payables

16

(80,975)

(338,233)

Β 

Borrowings

17

-Β 

(479,784)

Β 

─────────

─────────

Β 

Net current assets/(liabilities)

457,150Β 

(723,814)

Β 

─────────

─────────

Β 

Net assets/(liabilities)

458,524Β 

(723,814)

Β 

═════════

═════════

Β 

Β 

EQUITY

Β 

Share capital

20

2,657,234Β 

2,304,398Β 

Β 

Share premium account

6,732,714Β 

6,063,208Β 

Β 

Equity component - convertible loan note

-Β 

100,216Β 

Β 

Capital redemption reserve

43,333Β 

43,333Β 

Β 

Merger reserve

2,416,667Β 

2,416,667Β 

Β 

Profit and loss account

(11,391,424)

(11,651,636)

Β 

─────────

─────────

Β 

Total shareholders' equity/(deficit)

458,524Β 

(723,814)

Β 

═════════

═════════

Β 

Β 

Β 

The financial statements were approved by the Board on .........................

Β 

Β 

..............................

Β 

Edward Dawson

William Smith

Β 

Director

Director

Β 

Β 

Company Registration No. 03896382

Β 

Β 

The notes on pages 17 - 42 form an integral part of the financial statements.

Β 

Β 

Β 

Β 

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

FOR THE YEAR ENDED 31 DECEMBER 2015

Β 

Share capital

Share premium

Retained earnings

Foreign currency reserve

Capital redemption reserve

Merger reserve

Non controlling interests

Convertible loan note

Total

Β 

Β£

Β£

Β£

Β£

Β£

Β£

Β£

Β£

Β£

Β 

Β 

Balance at 1 January 2014

2,288,898Β 

6,059,750Β 

(7,722,515)

(3,874)

43,333Β 

2,416,667Β 

598,512Β 

89,283Β 

3,770,054Β 

Β 

Changes in equity for 2013

-Β 

Β 

Total comprehensive income for the year

-Β 

-Β 

(3,809,213)

-Β 

-Β 

-Β 

(771,232)

-Β 

(4,580,445)

Β 

Issue of shares

15,500Β 

7,750Β 

-Β 

-Β 

-Β 

-Β 

-Β 

-Β 

23,250Β 

Β 

Costs in respect of shares issued

-Β 

(4,292)

-Β 

-Β 

-Β 

-Β 

-Β 

-Β 

(4,292)

Β 

Convertible loan note - equity component

17

-Β 

-Β 

-Β 

-Β 

-Β 

-Β 

-Β 

10,933Β 

10,933Β 

Β 

Currency translation differences on foreign currency net investments

-Β 

-Β 

-Β 

43,341Β 

-Β 

-Β 

5,855Β 

-Β 

49,196Β 

Β 

────────

────────

────────

────────

────────

────────

────────

────────

────────

Β 

Balance at 31 December 2014

2,304,398Β 

6,063,208Β 

(11,531,728)

39,467Β 

43,333Β 

2,416,667Β 

(166,865)

100,216Β 

(731,304)

Β 

Changes in equity in 2014

Β 

Total comprehensive income for the year

-Β 

-Β 

69,311Β 

-Β 

-Β 

-Β 

-Β 

-Β 

69,311Β 

Β 

Issue of shares

20

352,836Β 

723,314Β 

-Β 

-Β 

-Β 

-Β 

-Β 

-Β 

1,076,150Β 

Β 

Costs in respect of shares issued

-Β 

(53,808)

-Β 

-Β 

-Β 

-Β 

-Β 

-Β 

(53,808)

Β 

On completion of CVA

17

-Β 

-Β 

-Β 

-Β 

-Β 

-Β 

(100,216)

(100,216)

Β 

Equity-settled share-based payments

19

-Β 

-Β 

70,993Β 

-Β 

-Β 

-Β 

-Β 

-Β 

70,993Β 

Β 

On dispsoal of subsidiaries

-Β 

-Β 

-Β 

(39,467)

-Β 

-Β 

166,865Β 

-Β 

127,398Β 

Β 

────────

────────

────────

────────

────────

────────

────────

────────

────────

Β 

Balance at 31 December 2015

2,657,234Β 

6,732,714Β 

(11,391,424)

-Β 

43,333Β 

2,416,667Β 

-Β 

-Β 

458,524Β 

Β 

════════

════════

════════

════════

════════

════════

════════

════════

════════

Β 

Β 

Merger reserve_

Β 

The merger reserve has been created as a result of the acquisition of the whole of the issued share capital of Central Asia Resources Limited ('CAR') by the Company in exchange for shares in the Company and the nominal value. It represents the difference between the fair value of the share capital issued by the Company and the nominal value.

Β 

Β 

Β 

COMPANY STATEMENT OF CHANGES IN EQUITY

FOR THE YEAR ENDED 31 DECEMBER 2015

-Β 

Β 

Share capital

Share premium

Retained earnings

Capital redemption reserve

Merger reserve

Convertible loan note

Total

Β 

Β£

Β£

Β£

Β£

Β£

Β£

Β£

Β 

Β 

Balance at 1 January 2014

2,288,898Β 

6,059,750Β 

(6,998,504)

43,333Β 

2,416,667Β 

89,283Β 

3,899,427Β 

Β 

Changes in equity for 2013

Β 

Total comprehensive income for the year

-Β 

-Β 

(4,653,132)

-Β 

-Β 

-Β 

(4,653,132)

Β 

Issue of shares

15,500Β 

7,750Β 

-Β 

-Β 

-Β 

-Β 

23,250Β 

Β 

Costs in respect of shares issued

-Β 

(4,292)

-Β 

-Β 

-Β 

-Β 

(4,292)

Β 

Convertible loan note - equity component

17

-Β 

-Β 

-Β 

-Β 

-Β 

10,933Β 

10,933Β 

Β 

────────

────────

────────

────────

────────

────────

────────

Β 

Balance at 31 December 2014

2,304,398Β 

6,063,208Β 

(11,651,636)

43,333Β 

2,416,667Β 

100,216Β 

(723,814)

Β 

Β 

Changes in equity in 2014

Β 

Total comprehensive income for the year

-Β 

-Β 

189,219Β 

-Β 

-Β 

-Β 

189,219Β 

Β 

Β 

Issue of shares

20

352,836Β 

723,314Β 

-Β 

-Β 

-Β 

-Β 

1,076,150Β 

Β 

Costs in respect of shares issued

-Β 

(53,808)

-Β 

-Β 

-Β 

-Β 

(53,808)

Β 

Equity-settled share-based payments

19

-Β 

-Β 

70,993Β 

-Β 

-Β 

-Β 

70,993Β 

Β 

On completion of CVA

17

-Β 

-Β 

-Β 

-Β 

-Β 

(100,216)

(100,216)

Β 

────────

────────

────────

────────

────────

────────

────────

Β 

Balance at 31 December 2015

2,657,234Β 

6,732,714Β 

(11,391,424)

43,333Β 

2,416,667Β 

-Β 

458,524Β 

Β 

════════

════════

════════

════════

════════

════════

════════

Β 

Β 

Merger reserve_

Β 

The merger reserve has been created as a result of the acquisition of the whole of the issued share capital of Central Asia Resources Limited ('CAR') by the Company in exchange for shares in the Company. It represents the difference between the fair value of the share capital issued by the Company and nominal value.

Β 

Β 

Β 

Β 

CONSOLIDATED STATEMENT OF CASH FLOWS

FOR THE YEAR ENDED 31 DECEMBER 2015

2015

2014

Β 

Β£

Β£

Β£

Β£

Β 

Cash flows from operating activities

Β 

Operating loss

(601,892)

(615,023)

Β 

Depreciation of property, plant and equipment

425Β 

2,946Β 

Β 

Increase in inventories

-Β 

(977)

Β 

Increase in trade and other receivables

(130,552)

(17,483)

Β 

(Decrease)/increase in trade and other payables

(96,409)

87,308Β 

Β 

Equity-settled share based payments

70,993Β 

-Β 

Β 

Other movement

33,955Β 

85,516Β 

Β 

─────────

─────────

Β 

Net cash used in operating activities - continuing operations

(723,480)

(457,713)

Β 

Β 

Investing activities

Β 

Finance income

162Β 

34Β 

Β 

Finance expense

-Β 

(5,883)

Β 

─────────

─────────

Β 

Net cash generated from/(used in) investing activities

162Β 

(5,849)

Β 

Β 

Β 

Capital expenditure

Β 

Payments to acquire intangible assets

-Β 

(12,333)

Β 

Payments to acquire tangible assets

(1,699)

(196)

Β 

─────────

─────────

Β 

Net cash outflow for capital expenditure

(1,699)

(12,529)

Β 

Β 

Acquisitions and disposals

Β 

Cash on disposal of subsidiary undertaking

(247)

-Β 

Β 

─────────

─────────

Β 

Net cash outflow for acquisitions and disposals

(247)

-Β 

Β 

Β 

Financing activities

Β 

Issue of share capital

1,076,150Β 

-Β 

Β 

Proceeds received from issue of derivative financial asset

12,404Β 

148,578Β 

Β 

Cost of share issue

(53,808)

(4,292)

Β 

Convertible unsecured loan notes

50,000Β 

80,000Β 

Β 

─────────

─────────

Β 

Net cash generated from financing activities

1,084,746Β 

224,286Β 

Β 

─────────

─────────

Β 

Net increase/(decrease) in cash and cash equivalents in year

359,482Β 

(251,805)

Β 

Β 

Cash and cash equivalents at beginning of the year

22,734Β 

274,539Β 

Β 

─────────

─────────

Β 

Cash and cash equivalents at end of the year

382,216Β 

22,734Β 

Β 

═════════

═════════

Β 

Β 

The notes on pages 17 - 42 form an integral part of these financial statements.

Β 

Β 

COMPANY STATEMENT OF CASH FLOWS

FOR THE YEAR ENDED 31 DECEMBER 2015

2015

2014

Β 

Β£

Β£

Β£

Β£

Β 

Β 

Cash flows from operating activities

Β 

Operating loss

(540,239)

(452,055)

Β 

Depreciation of property, plant and equipment

425Β 

-Β 

Β 

Increase in trade and other receivables

(130,552)

(104,147)

Β 

Increase in trade and other payables

(158,062)

90,318Β 

Β 

Equity-settled share based payments

70,993Β 

-Β 

Β 

Other movement

33,955Β 

-Β 

Β 

─────────

─────────

Β 

Net cash used in operating activities

(723,480)

(465,884)

Β 

Β 

Investing activities

Β 

Finance income

162Β 

34Β 

Β 

Finance expense

-Β 

(5,884)

Β 

─────────

─────────

Β 

Net cash generated from/(used in) investing activities

162Β 

(5,850)

Β 

Β 

Capital expenditure

Β 

Payments to acquire tangible assets

(1,699)

-Β 

Β 

─────────

─────────

Β 

Net cash inflow for capital expenditure

(1,699)

-Β 

Β 

Β 

Β 

Financing activities

Β 

Issue of share capital

1,076,150Β 

-Β 

Β 

Proceeds received from issue of derivative financial asset

12,404Β 

148,578Β 

Β 

Cost of share issue

(53,808)

(4,292)

Β 

Convertible unsecured loan notes

50,000Β 

80,000Β 

Β 

─────────

─────────

Β 

Net cash generated from financing activities

1,084,746Β 

224,286Β 

Β 

─────────

─────────

Β 

Net increase/(decrease) in cash and cash equivalents in the year

359,729Β 

(247,448)

Β 

Β 

Cash and cash equivalents at beginning of the year

22,487Β 

269,935Β 

Β 

─────────

─────────

Β 

Cash and cash equivalents at end of the year

382,216Β 

22,487Β 

Β 

═════════

═════════

Β 

Β 

Β 

Β 

NOTES TO THE FINANCIAL STATEMENTS

Β 

Β 

FOR THE YEAR ENDED 31 DECEMBER 2015

Β 

Β 

1

Accounting policies and basis of preparation

1.1

General information

Prospex Oil and Gas Plc (formerly Premier Gold Resources Plc) is incorporated in England and Wales and is quoted on the AIM Market of the London Stock Exchange Plc. The address of its registered office is Stonebridge House, Chelmsford Road, Hatfield Heath, Essex CM22 7BD. The registered number of the company is 03896382.

Β 

These financial statements are presented in pounds sterling because that is the currency of the primary economic environment in which the company operates.

1.2

Going concern

During the year ended 31 December 2015, the Directors proposal for a Company Voluntary Arrangement ("CVA") was approved by creditors and members. The Company also completed a settlement deed with Tridevi Capital Partner (I) LP ("Tridevi"), disposing of the entire issued share capital of Central Asia Resource Limited ("CAR"), the Company's wholly owned subsidiary, to Tridevi in full and final settlement of the outstanding loan of approximately Β£580,000 under the Convertible Loan Agreement. The Company also raised Β£1,076,150 (before expenses) through the issue of 35,283,591 New Ordinary Shares to advance the Company's Investing Policy, of which Β£50,000 was transferred to the Company in order to enable it to make an improved offer of settlement to the unsecured Creditors of the Company under the CVA. As a result of the above, the directors are of the opinion that the financial statements should be prepared on a going concern basis.

1.3

Basis of preparation

The Group financial statements have been prepared in accordance with International Financial Reporting Standards as adopted by the European Union, (IFRSs) and International Financial Reporting Interpretations Committee ('IFRIC') interpretations issued by the International Accounting Standards Board (IASB) as adopted by the European Union and with those parts of the Companies Act 2006 applicable to companies reporting under IFRS.

Β 

The Group financial statements have been prepared under the historical cost convention or fair value where appropriate.

1.4

Parent company profit and loss account

A separate profit and loss account for the parent company, Prospex Oil and Gas Plc, has been omitted under the provisions of Section 408 of the Companies Act 2006. The profit dealt with in the financial statements of the parent company was Β£189,219 (2014: loss - Β£4,653,132).

1.5

Basis of consolidation

The Group financial statements consolidate the financial statements of the Company and all its subsidiaries ('the Group'). Subsidiaries include all entities over which the Group has the power to govern financial and operating policies. The existence and effect of potential voting rights that are currently exercisable or convertible are considered when assessing whether the Group controls another entity. Subsidiaries are consolidated from the date on which control commences until the date that control ceases. Intra-group balances and any unrealised gains and losses on income or expenses arising from intra-group transactions, are eliminated in preparing the consolidated financial statements.

Non-controlling interests in the net assets of consolidated subsidiaries are identified separately from the Group's equity therein. Non-controlling interests consist of the amount of those interests at the date of the original business combination and their share of changes in equity since the date of the combination.

Β 

1.6

Business combination

The Group adopts the acquisition method in accounting for the acquisition of subsidiaries. On acquisition the cost is measured at the fair value of the assets given, plus equity instruments issued and liabilities incurred or assumed at the date of exchange. The assets acquired and liabilities and contingent liabilities assumed in a business combination are measured at their fair value at the date of acquisition. Any excess of the fair value of the consideration over the fair value of the identifiable net assets acquired is recorded as goodwill.

Β 

Any deficiency of the fair value of the consideration below the fair value of identifiable net assets acquired is credited to the income statement in the period of the acquisition.

Β 

Where necessary, adjustments are made to the financial statements of subsidiaries to bring the accounting policies used into line with those used by the Group.

1.7

Goodwill

Goodwill on acquisition of subsidiaries represents the excess of the cost of acquisition over the fair value of the Group's share of the net identifiable net assets and contingent liabilities acquired. Identifiable assets are those which can be sold separately or which arise from legal rights regardless of whether those rights are separable. Goodwill on acquisition of subsidiaries is included in intangible assets. Goodwill is not amortised but tested annually, or when trigger events occur, for impairment and is carried at cost less accumulated impairment losses.

Goodwill is initially recognised at fair value. Any negative goodwill is credited to the income statement in the year of acquisition. If an undertaking is subsequently sold, the amount of goodwill carried on the balance sheet at the date of disposal is charged to the income statement in the period of disposal as part of the gain or loss on disposal.

1.8

Property plant and equipment

Property, plant and equipment are stated at cost less depreciation. Depreciation is provided at rates calculated to write off the cost less estimated residual value of each asset over its expected useful life, as follows:

Land and buildings - Leasehold

over the length of the lease

Fixtures, fittings & equipment

1 - 5 years, straight line

Motor vehicles

3 - 9 years, straight line

1.9

Inventories

Inventories are stated at the lower of cost and net realisable value. Cost comprises all costs of purchase and other costs incurred in bringing the inventories to their present location and condition.

1.10

Impairment of non-financial assets

Assets that have an indefinite useful life, for example goodwill, are not subject to amortisation and are tested annually for impairment. Assets that are subject to amortisation are tested for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. An impairment loss is recognised for the amount by which the asset's carrying amount exceeds its recoverable amount. The recoverable amount is the higher of an asset's fair value less costs to sell and value in use. For the purposes of assessing impairment, assets are grouped at the lowest levels for which there are separately identifiable cash flows (Cash Generating Units). Non-financial assets other than goodwill that have suffered impairment are reviewed for possible reversal of the impairment at each reporting date.

1.11

Financial instruments

Financial assets and financial liabilities are recognised on the Group's balance sheet when the Group becomes a party to the contractual provisions of the instrument.

1.12

Loans and receivables

Β 

Β 

These assets are non-derivative financial assets with fixed or determinable payments that are not quoted in an active market. The principal financial assets of the company are loans and receivables, which arise principally through the provision of goods and services to customers (e.g. trade receivables) but also incorporate other types of contractual monetary asset. They are included in current assets, except for maturities greater than 12 months after the balance sheet date. These are classified as non-current assets.

The Group's loans and receivables are recognised and carried at the lower of their original amount less an allowance for any doubtful amounts. An allowance is made when collection of the full amount is no longer considered possible.

The Group's loans and receivables comprise trade and other receivables and cash and cash equivalents in the consolidated statement of financial position.

Cash and cash equivalents include cash at bank and in hand and short-term deposits with an original maturity of three months or less.

1.13

Derivative financial instruments

Derivative financial instruments are initially recognised at fair value on the date a derivative contract is entered into and are subsequently carried at fair value with the changes in fair value recognised in the income statement.

1.14

Trade and other payables

Trade and other payables are initially measured at fair value and subsequently measured at amortised cost using the effective interest rate method.

1.15

Convertible debt

The component of convertible debt that exhibits characteristics of debt is recognised as a liability in the Statement of Financial Position, net of transaction costs. On issue of convertible debt, the fair value of the liability component is determined using a market rate for an equivalent non-convertible bond and this amount is carried as a liability on the amortised cost basis until extinguished on conversion or redemption. The increase in the liability due to the passage of time is recognised as a finance cost. The remainder of the proceeds is allocated to the equity component and is recognised in shareholders' equity. The carrying amount of the equity component is not re-measured in subsequent years. Borrowings are classified as current liabilities unless the Group has an unconditional right to defer settlement of the liability for at least 12 months after the balance sheet date.

Β 

1.16

Financial liabilities and equity

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities.

Β 

Where the contractual obligations of financial instruments (including share capital) are equivalent to a similar debt instrument, those financial instruments are classed as financial liabilities. Financial liabilities are presented as such in the balance sheet. Finance costs and gains or losses relating to financial liabilities are included in the profit and loss account. Finance costs are calculated so as to produce a constant rate of return on the outstanding liability.

Β 

Where the contractual terms of share capital do not have any terms meeting the definition of a financial liability then this is classed as an equity instrument. Dividends and distributions relating to equity instruments are debited direct to equity.

Β 

Equity comprises the following:

- Share capital represents the nominal value of equity shares;

- Share premium represents the excess over nominal value of the fair value of consideration received for equity shares, net of expenses of the share issue;

- Profit and loss reserve represents retained deficit;

- Other reserve represents the capital redemption reserve arising on redemption of shares in previous years and own share reserve.

1.17

Equity-settled share-based payment

The Company makes equity-settled share-based payments. The fair value of options and warrants granted is recognised as an expense, with a corresponding increase in equity. The fair value is measured at grant date and spread over the vesting period, which is the period over which all of the specified vesting conditions are to be satisfied. The fair value of the options granted is measured based on the Black-Scholes framework, taking into account the terms and conditions upon which the instruments were granted. At each balance sheet date, the Company revises its estimate of the number of options that are expected to become exercisable. It recognises the impact of the revision to original estimates, if any, in the income statement, with a corresponding adjustment to equity.

1.18

Foreign currency translation

Transactions in currencies other than Sterling, the presentational and functional currency of the Company, are recorded at the rates of exchange prevailing on the dates of the transactions. At each balance sheet date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the balance sheet date. Non-monetary assets and liabilities carried at fair value that are denominated in foreign currencies are translated at the rates prevailing at the date when the fair value was determined. Gains and losses arising on retranslation are included in the income statement for the period, except for exchange differences on non-monetary assets and liabilities, which are recognised directly in equity, where the changes in fair value are recognised directly in equity

On consolidation, the assets and liabilities of the Group's overseas entities (none of which has the currency of a hyper-inflationary economy) are translated at exchange rates prevailing on the balance sheet date. Income and expense items are translated at the average exchange rates for the period. Exchange differences arising, if any, are classified as equity and transferred to the Group's translation reserve. Such translation differences are recognised as income or as expenses in the period in which the operation is disposed of.

1.19

Taxation

The income tax expense or taxation recoverable represents the sum of tax currently payable or recoverable and deferred tax.

Β 

The tax currently payable is based on the taxable profit for the period using the tax rates that have been enacted or substantially enacted by the balance sheet date. Taxable profit differs from the net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible.

Β 

Deferred tax is provided in full, using the liability method, on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts for financial reporting purposes. Deferred tax is determined using tax rates that have been enacted or substantially enacted at the balance sheet date and are expected to apply when the related deferred income tax asset is realised or the deferred tax liability is settled. Deferred tax is charged or credited in the income statement, except when it relates to items charged or credited to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets are only recognised to the extent that it is probable that future taxable profit will be available against which the asset can be utilised.

1.20

Leasing

Rentals payable under operating leases are charged against income on a straight line basis over the lease term.

1.21

Pensions

The company operates a defined contribution scheme for the benefit of its employees. Contributions payable are charged to the profit and loss account in the year they are payable.

Β 

1.22

Accounting Standards issued but not yet effective and/or adopted

As at the date of approval of these financial statements, the following standards were in issue but not yet effective. These standards have not been adopted early by the company as they are not expected to have a material impact on the company's financial statements.

Effective date (period beginning on or after)

IFRS 2

Share based payments - Amendments resulting from the annual improvements cycle 2010-2012 (definition of "vesting conditions")

01/02/2015

IFRS 3

Business combinations - Amendments resulting from the annual improvements cycle 2010-2012 (scope exception for joint ventures")

01/02/2015

IFRS 3

Business combinations - Amendments resulting from the annual improvements cycle 2011-2013 (scope exception for joint ventures")

01/01/2015

IFRS 5

Non-current assets held for sale and discontinued operations - Amendments resulting from September 2014 annual improvements to IFRSs

01/01/2016

IFRS 7

Financial instruments disclosure - Amendments resulting from September 2014 annual improvements to IFRSs

01/01/2016

IFRS 8

Operating segments - Amendments resulting from the annual improvements cycle 2010-2012 (aggregation of segments, reconciliation of segment assets)

01/02/2015

IFRS 9

Financial instruments - incorporating requirements for classification and measurement, impairment, general hedge accounting and de-recognition

01/01/2018

IFRS 10

Consolidated financial statements - Amendments regarding the the application of consolidation exception

01/01/2016

IFRS 12

Disclosure of interests in other entities - Amendments regarding the the application of consolidation exception

01/01/2016

IFRS 13

Fair value measurement - Amendments resulting from the annual improvements cycle 2011-2013 (scope of the portfolio exception)

01/01/2015

IAS 1

Presentation of financial Statements - Amendments resulting from the disclosure initiative

01/01/2016

IAS 7

Statement of cash flows - Amendments resulting from the disclosure initiative

01/01/2017

IAS 12

Income taxes - Amendments regrading recognition of deferred tax assets for unrealised losses

01/01/2017

IAS 16

Property, plant and equipment - Amendments resulting from the annual improvements cycle 2010-2012 (proportionate restatement of accumulated depreciation on revaluation)

01/02/2015

IAS 16

Property, plant and equipment - clarification of acceptable methods of depreciation and amortisation and amendments bringing bearer plants into the scope of IAS 16

01/01/2016

IAS 16

Property, plant and equipment - Amendments bringing bearer plants into scope of IAS 16

01/01/2016

IAS 19

Employee benefits - Amendment to clarify the requirements that relate to how contributions from employees or third parties that are linked to service should be attributed to periods of service

01/02/2015

IAS 19

Employee benefits - Amendment resulting from September 2014 Annual Improvements to IFRSs

01/01/2016

Β 

IAS 24

Related party disclosures -Amendments resulting from annual improvements 2010-2012 cycle (management entities)

01/02/2015

Β 

IAS 27

Separate financial statements - Amendments reinstating the equity method as an accounting option for investments in subsidiaries, joint ventures and associates in an entity's separate financial statements

01/01/2016

Β 

IAS 28

Investments in associates and joint ventures - Amendments regarding the application of the consolidation exception

01/01/2016

Β 

IAS 36

Impairment of assets - clarification of acceptable methods of depreciation and amortisation

01/01/2016

Β 

IAS 38

Intangible assets - Amendments resulting from annual improvements 2010-2012 cycle (proportionate restatement of accumulated depreciation and revaluation)

01/02/2015

Β 

IAS 39

Intangible assets - Amendments regarding the clarification of acceptable methods of depreciation and amortisation

01/02/2015

Β 

Β 

The International Financial Reporting Interpretations Committee has also issued interpretations which the company does not consider will have a significant impact on the financial statements.

Β 

Β 

2

Critical accounting estimates and judgements

Β 

The preparation of the financial information in conformity with IFRS requires the use of certain critical accounting estimates that affect the reported amounts of assets and liabilities at the date of the financial information and the reported amounts of revenue and expenses during the reporting period. Although these estimates are based on management's best knowledge of the amounts, events or actions, actual results ultimately may differ from these estimates. The estimates and underlying assumptions are as follows:

Β 

Β 

Β 

Β 

Β 

Impairment of assets

Β 

The Group is required to test, on an annual basis, whether its non-current assets have suffered any impairment. Determining whether these assets are impaired requires an estimation of the value in use of the cash-generating units to which the assets have been allocated. The value in use calculation requires the Directors to estimate the future cash flows expected to arise from the cash-generating unit and a suitable discount rate in order to calculate the present value. Subsequent changes to the cash generating unit allocation or to the timing of cash flows could impact on the carrying value of the respective assets.

Β 

Β 

Recoverability of other financial assets

Β 

The majority of the Company's financial assets represent loans provided to its subsidiary, which are associated with funding of mineral exploration and development projects. The recoverability of such loans is dependent upon the discovery of economically recoverable reserves, the ability of the Company to maintain necessary financing to complete the development of the reserves and future profitable production or proceeds from the disposition thereof.

Β 

Β 

Share based payments

Β 

The estimates of share based payments requires that management selects an appropriate valuation model and make decisions on various inputs into the model including the volatility of its own share price, the probable life of the options before exercise, and behavioural consideration of employees.

Β 

Β 

Β 

Deferred tax assets

Β 

Deferred taxation is provided for using the liability method. Deferred tax assets are recognised in respect of tax losses where the Directors believe that it is probable that future profits will be relieved by the benefit of tax losses brought forward. The Board considers the likely utilisation of such losses by reviewing budgets and medium term plans for each taxable entity within the Group. The Directors have decided that no deferred tax asset should be recognised at 31 December 2014. If the actual profits earned by the Group differs from the budgets and forecasts used then the value of such deferred tax assets may differ from that shown in these financial statements.

Β 

Β 

Valuation of derivative financial asset

Β 

The Company placed 250 million shares with Lanstead Capital L.P. ('Lanstead') for a consideration of Β£1 million and a second tranche of 150 million shares for a consideration of Β£260,000. At the same time, the Company and Lanstead entered into equity swap and interest rate swap agreements in respect of the placings for which consideration will be received on a monthly basis over a 24 month period (note 16). The amount receivable each month is dependent on the Company's share price at the settlement date. The Directors have made assumptions in the financial statements about the funds receivable at the year end. However, there is significant uncertainty underlying these assumptions due to the unpredictable nature of the share price.

Β 

Β 

3

Segmental information

Β 

Β 

In April 2015, the Company disposed of its one primary business segment, gold and precious mineral exploration and in one principal geographical area, Kyrgyzstan. Details of the profit and loss in respect of this disposal are disclosed in note 11 to the accounts under dispsoal of subsidiaries.

Β 

Following the disposal, the Company became an Investing Company. The results for this continuing operation, all of which were carried out in the UK, are disclosed in the Income Statement. The net assets as at 31 December 2015 as shown on the Statement of Financial Position all relate to the Investment activity.

Β 

Β 

4

Operating loss

Β 

2015

2014

Β 

Β£

Β£

Β 

Operating loss is stated after charging:

Β 

Depreciation of tangible assets

425Β 

2,946Β 

Β 

Loss on foreign exchange transactions

250Β 

81,850Β 

Β 

Auditors' remuneration

- Fees payable to the company's auditor for the audit of the company's financial statements

17,545Β 

19,500Β 

Β 

- Fees payable to the company's auditors for non-audit services

2,000Β 

-Β 

Β 

═══════

═══════

Β 

Β 

5

Finance income

Β 

2015

2014

Β 

Β£

Β£

Β 

Β 

Bank interest received

162Β 

34Β 

Β 

═══════

═══════

Β 

Β 

Β 

6

Finance costs

2015

2014

Β£

Β£

Other interest

-Β 

67,491Β 

═══════

═══════

7

Income tax expense

2015

2014

Β£

Β£

Domestic current year tax

Adjustment for prior years

(411)

-Β 

───────

───────

Total tax expenses

(411)

-Β 

═══════

═══════

Factors affecting the tax charge for the year

Profit/(loss) before income taxation

68,900Β 

(4,580,445)

═══════

═══════

Profit/(loss) on ordinary activities before taxation multiplied by standard rate of UK corporation tax of 20.00% (2014 - 20.00%)

13,780Β 

(916,089)

───────

───────

Effects of:

Non deductible expenses

20,207Β 

803,977Β 

Depreciation add back

85Β 

-Β 

Capital allowances

(340)

-Β 

Tax losses not utilised

(80,650)

112,112Β 

Prior year

(411)

-Β 

Other tax adjustments

46,918Β 

-Β 

───────

───────

(14,191)

916,089Β 

───────

───────

Total tax expense

(411)

-Β 

═══════

═══════

There is no provision for UK Corporation Tax due to adjusted losses for tax purposes, subject to agreement with HM Revenue and Customs. The deferred asset arising from the accumulated tax losses of approximately Β£3.4m (2014: Β£3.2m) carried forward has not been recognised but may become recoverable against future trading profits.

8

Earnings/loss per share

The loss and number of shares used in the calculation of earnings per ordinary share are set out below:

2015

2014

Β£

Β£

Basic:

Continuing operations

(502,434)

(687,701)

Discontinued operations

571,745Β 

(3,121,512)

─────────

─────────

Loss for the financial period

69,311Β 

(3,809,213)

═════════

═════════

Weighted average of ordinary shares

30,677,884Β 

5,444,473Β 

═════════

═════════

There was no dilutive effect from the options outstanding during the period (note 19).

The number of shares included in the comparative figure for 2014 has been updated to give effect to the restructuring of the share capital which took place during the current year (note 20).

9

Tangible fixed assets

Β 

Plant and machinery

Β 

Β£

Β 

Cost

Β 

At 1 January 2015

13,872Β 

Β 

Additions

1,699Β 

Β 

Disposals

(13,872)

Β 

───────

Β 

At 31 December 2015

1,699Β 

Β 

───────

Β 

Depreciation

Β 

At 1 January 2015

3,517Β 

Β 

On disposals

(3,517)

Β 

Charge for the year

425Β 

Β 

───────

Β 

At 31 December 2015

425Β 

Β 

───────

Β 

Net book value

Β 

At 31 December 2015

1,274Β 

Β 

═══════

Β 

At 31 December 2014

10,355Β 

Β 

═══════

Β 

Β 

Β 

10

Investments in subsidiary undertakings

Β 

Β 

The Company

Β 

Β£

Β 

Cost

Β 

At 1 January 2015

2,503,270Β 

Β 

Additions

100Β 

Β 

Disposals

(2,503,270)

Β 

───────

Β 

At 31 December 2015

100Β 

Β 

───────

Β 

Provisions for diminution in value

Β 

At 1 January 2015

2,503,270Β 

Β 

On disposals

(2,503,270)

Β 

───────

Β 

At 31 December 2015

-Β 

Β 

───────

Β 

Net book value

Β 

At 31 December 2015

100Β 

Β 

═══════

Β 

At 31 December 2014

-Β 

Β 

═══════

Β 

Β 

Subsidiary undertakings:

Β 

During the year, the Company disposed of its entire shareholding of the following companies.

Β 

Β 

Country of registration or

Shares held

Β 

Company

incorporation

Class

%

Β 

Central Asia Resources Limited

England & Wales

Ordinary

100

Β 

Premier Asia Resources LLC

Kyrgyz Republic

Ordinary

80

Β 

Β 

During the year, the Company acquired the entire shareholding of the following company.

Β 

Β 

PXOG County Limited

England & Wales

Ordinary

100

Β 

Β 

Β 

11

Disposal of subsidiaries

On 14 April 2015, the Company disposed of Central Asia Resources Limited, being the holding company of Premer Asia Resources LLC and the company that holds the Group's 80% interest in the Exploration Licence in the Kyrgyz Republic.

Consideration received

Β£

Settlement of Convertible Loan Note

580,000Β 

Additional consideration

50,000Β 

Interest accrued on the Convertible Loan Note

61,653Β 

───────

691,653Β 

═══════

Assets and liabilities over which control was lost

Β£

Current assets

Inventories

977Β 

Trade and other receivables

8,571Β 

Cash and cash equivalents

247Β 

Non-current assets

Property, plant and equipment

10,355Β 

Current liabilities

Trade and other payables

(27,640)

───────

Net liabilities disposed of

(7,490)

═══════

Gain on dispsoal of subsidiary

Β£

Consideration received

691,653Β 

Net liabilities disposed of

7,490Β 

Cumulative exchange gain in respect of the net assets of the subsidiaries reclassified from equity to profit or loss on loss of control of subsidiaries

39,467Β 

Minority interest's share of net assets of subsidiaries

(166,865)

───────

571,745Β 

═══════

The gain on disposal is included in the profit for the year from discontinued operations.

Net cash inflow on disposal of subsidiaries

Β£

Additional consideration in cash and cash equivalents

50,000Β 

Less: cash and cash equivalent balances disposed of

(247)

───────

49,753Β 

═══════

Β 

Β 

Analysis of profit/(loss) for the year from discontinued operations

Β 

The results of the discontinued operations included in the profit/loss for the year are set out below. The comparative loss and cash flows from discontinued operations have been re-presented to include those operations classified as discontinued in the current year.

Β 

Β 

2015

2014

Β 

Β£

Β£

Β 

Β 

Administrative expenses

-Β 

(162,967)

Β 

Impairment charges

-Β 

(3,729,777)

Β 

───────

───────

Β 

-Β 

(3,892,744)

Β 

Gain on disposal of operation

571,745Β 

-Β 

Β 

───────

───────

Β 

Profit/(loss) for the year from discontinued operations

571,745Β 

(3,892,744)

Β 

═══════

═══════

Β 

Β 

Cash flows from discontinued operations

Β 

2015

2014

Β 

Β£

Β£

Β 

Β 

Net cash outflows from operating activities

-Β 

(4,357)

Β 

Net cash inflows from financing activities

50,000Β 

-Β 

Β 

───────

───────

Β 

Net cash inflows/(outflows)

50,000Β 

(4,357)

Β 

═══════

═══════

Β 

Β 

12

Inventories

2015

2014

The Group

Β£

Β£

Finished goods and goods for resale

-Β 

977Β 

═══════

═══════

13

Trade and other receivables

The Group

The Company

2015

2014

2015

2014

Β£

Β£

Β£

Β£

Trade receivables

-Β 

7,451Β 

-Β 

-Β 

Other receivables

138,779Β 

14,434Β 

138,779Β 

13,314Β 

Prepayments and accrued income

17,130Β 

12,043Β 

17,130Β 

12,043Β 

───────

───────

───────

───────

155,909Β 

33,928Β 

155,909Β 

25,357Β 

═══════

═══════

═══════

═══════

The Directors consider that the carrying amount of trade and other receivables approximates to their fair value.

Β 

14

Derivative financial assets

2015

2014

Β£

Β£

Due within one year

-Β 

46,359Β 

═════════

═════════

Lanstead 1 Agreement

In December 2012, the Company issued 250 million new shares of 0.1p per share at a price of 0.4p per share to Lanstead Capital L.P. ('Lanstead') with a notional value of Β£1 million. The Company entered into an equity swap price mechanism with Lanstead for a notional 75% of these shares with a notional reference price of 0.5333p per share. Lanstead have hedged the consideration they pay for shares in the Company against the performance of the Company's share price over a 24 month period. All 250 million shares were allotted with full rights on the date of the transaction.

Β 

To the extent that the share price is greater or lower than the reference price at each swap settlement, the Company will receive greater or lower consideration calculated on pro-rata basis i.e. share price / reference price multiplied by the monthly transfer amount. The valuation for each settlement is determined to be the average share price for the preceding 5 trading days up to settlement date.

Β 

As the amount of the consideration receivable by the Company from Lanstead will vary subject to the change in the Company's share price and will be settled in the future, the receivable is treated as a derivative financial asset and has been designated at fair value through profit or loss.

Β 

The Company also issued 25 million shares to Lanstead as a value payment in connection with the equity swap agreement.

Β 

The fair value of the derivative financial assets has been determined by reference to the Company's share price and has been estimated as follows:

Share price

Notional number of shares outstanding

Fair value

Β£

Value of derivative financial assets at 1 January 2014

0.14p

109,375,000Β 

153,125Β 

Consideration received

(93,750,000)

(96,988)

Loss on revaluation of derivative financial asset

(47,278)

─────────

─────────

Value of derivative financial assets at 31 December 2014

0.05p

15,625,000Β 

8,859Β 

Consideration received

(15,625,000)

(8,859)

Loss on revaluation of derivative financial asset

-Β 

─────────

─────────

Value of derivative financial assets at 31 December 2015

-Β 

-Β 

═════════

═════════

Β 

Lanstead 2 Agreement

Β 

In December 2013, the Company issued 200 million new shares of 0.1p per share at a price of 0.13p per share to Lanstead Capital L.P. ('Lanstead') with a notional value of Β£260,000. The Company entered into an equity swap price mechanism with Lanstead for a notional 75% of these shares with a notional reference price of 0.17333p per share. Lanstead have hedged the consideration they pay for shares in the Company against the performance of the Company's share price over a 24 month period. All 150 million shares were allotted with full rights on the date of the transaction.

Β 

Β 

The Company also issued 20 million shares to Lanstead as a value payment in connection with the equity swap agreement.

Β 

Β 

As with the Lanstead 1 Agreement, the consideration receivable from Lanstead has been treated as a derivative financial asset and has been designated at fair value through profit or loss. The fair value of the derivative financial asset has been determined by reference to the Company's share price and has been estimated as follows:

Β 

Β 

Share price

Notional number of shares outstanding

Fair value

Β 

Β£

Β 

Β 

Β 

Value of derivative financial assets at 1 January 2014

0.14p

150,000,000Β 

210,000Β 

Β 

Β 

Consideration received

(75,000,000)

(51,590)

Β 

Gain on revaluation of derivative financial asset

(120,910)

Β 

─────────

─────────

Β 

Value of derivative financial assets at 31 December 2014

0.05p

75,000,000Β 

37,500Β 

Β 

Β 

Consideration received

(75,000,000)

(3,545)

Β 

Other movement

(33,955)

Β 

Β 

─────────

─────────

Β 

Value of derivative financial assets at 31 December 2015

-Β 

-Β 

Β 

═════════

═════════

Β 

Β 

15

Cash and cash equivalents

The Group

The Company

2015

2014

2015

2014

Β£

Β£

Β£

Β£

Cash at bank and in hand

382,216Β 

22,734Β 

382,216Β 

22,487Β 

═══════

═══════

═══════

═══════

The Directors consider that the carrying amount of cash and cash equivalents approximates to their fair value. All of the Company's cash and cash equivalents are at floating rates of interest.

Β 

Β 

16

Trade and other payables

The Group

The Company

2015

2014

2015

2014

Β£

Β£

Β£

Β£

Trade payables

1,349Β 

138,096Β 

1,349Β 

137,989Β 

Corporation tax

-Β 

411Β 

-Β 

411Β 

Other taxes and social security costs

9,829Β 

1,580Β 

9,829Β 

771Β 

Other payables

26,751Β 

138,321Β 

26,851Β 

111,597Β 

Accruals and deferred income

42,946Β 

87,465Β 

42,946Β 

87,465Β 

────────

────────

────────

────────

80,875Β 

365,873Β 

80,975Β 

338,233Β 

════════

════════

════════

════════

The Directors consider that the carrying amount of trade and other payables approximates to their fair value.

17

Borrowings

2015

2014

Β 

Β£

Β£

Β 

Β 

Convertible loan note

-Β 

479,784Β 

Β 

═══════

═══════

Β 

Β 

In 2013, the Company entered into a convertible loan note agreement for Β£1 million of which Β£500,000 was drawn down by 31 December 2013, with further draw downs totalling Β£80,000 during 2014. The interest rate on the loan is 10% per annum. The loan matures five years from the issue date at their nominal value. The Loan Note Holder can convert their loan, and accrued interest, into shares at the holder's option commencing six months after the issue date of the loan and up to the maturity date at the rate of 500 shares per Β£1. The Company has the right to repay the loan at any time up to the maturity date. The values of the liability component and the equity conversion component were determined at issuance of the loan.

Β 

The convertible loan recognised in the balance sheet is calculated as follows:

Β 

Β 

2015

2014

Β 

Β£

Β£

Β 

Β 

Nominal value of convertible loan issued

-Β 

580,000Β 

Β 

Equity component

-Β 

(100,216)

Β 

───────

───────

Β 

Liability component on initial recognition and at 31 December 2015

-Β 

479,784Β 

Β 

═══════

═══════

Β 

Β 

Interest of Β£nil (2014: Β£61,608) has been charged in respect of the convertible loan note to the statement of comprehensive income and included in trade and other payables under accruals and deferred income.

Β 

Β 

Β 

Β 

18

Pension and other post-retirement benefit commitments

Β 

Β 

Defined contribution

Β 

Β 

2015

2014

Β 

Β£

Β£

Β 

Β 

Contributions payable by the company for the year

7,125Β 

-Β 

Β 

═══════

═══════

Β 

Β 

19

Share-based payments

Share options

At 31 December 2014 and 31 December 2015 outstanding awards to subscribe for ordinary shares of 1p each in the Company, granted in accordance with the rules of the share option scheme, were as follows:

31 December 2014

Shares under option

Weighted average remaining contractual life (years)

Weighted average exercise price (pence)

Brought forward

273,400Β 

7.6

157.5

Granted

-Β 

-Β 

-Β 

Lapsed

(5,000)

-Β 

(562.5)

────────

────────

────────

Carried forward

268,400Β 

6.3

150Β 

════════

════════

════════

31 December 2015

Shares under option

Weighted average remaining contractual life (years)

Weighted average exercise price (pence)

Brought forward

268,400Β 

6.3

150

Granted

3,659,116Β 

-Β 

3.05

Lapsed

(24,000)

-Β 

(2.08)

────────

────────

────────

Carried forward

3,903,516Β 

9.1

0.9

════════

════════

════════

All options were exercisable at the year end. No options were exercised during the year.

The number of share options included in the comparative figures for 2014, and the weighted average exercise price, have been updated to give effect to the restructuring of the share capital which took place during the year (note 20).

Β 

Β 

The following share-based payment arrangements were in existence during the current and prior years.

Options

Number

Expiry date

Exercise price

Fair value at grant date

1. Granted 18 November 2005

16,000Β 

18/11/2015

250.0p

10.0p

2. Granted 31 July 2007

36,400Β 

31/07/2017

250.0p

82.5p

3. Granted 30 April 2012

208,000Β 

30/04/2022

125.0p

47.5p

4. Granted 1 September 2012

8,000Β 

01/09/2022

125.0p

5.0p

5. Granted 16 April 2015

2,847,116Β 

15/04/2025

3.0p

1.94p

6. Granted 16 April 2015

812,000Β 

15/04/2018

3.0p

1.94p

The fair value of remaining share options has been calculated using the Black Scholes model. The assumptions used in the calculation of the fair value of the share options outstanding during the year are as follows:

Options

Grant date share price

Exercise price

Expected volatility

Expected option life

Risk-free interest rate

1. Granted 18 November 2005

37.5p

250.0p

100%

5 years

4.4%

2. Granted 31 July 2007

212.5p

250.0p

100%

5 years

4.4%

3. Granted 30 April 2012

175.0p

125.0p

32%

3.5 years

0.24% - 0.43%

4. Granted 1 September 2012

75p

125.0p

32%

3.5 years

0.24% - 0.43%

5. Granted 16 April 2015

4.0p

3.0p

71.5%

3 years

0.71%

6. Granted 16 April 2015

4.0p

3.0p

71.5%

3 years

0.71%

The fair value has been calculated assuming that there will be no dividend yield.

Volatility was determined by reference to the standard deviation of expected share price returns based on a statistical analysis of daily share prices over a 3 year period to grant date. All of the above options are equity settled and the charge for the year is Β£70,993 (2014: Β£nil).

Β 

Β 

20

Share capital

2015

2014

2015

2014

Number

Number

Β£

Β£

Allotted, called up and fully paid

Ordinary shares of 1p each

40,731,291Β 

407,313Β 

-Β 

Ordinary shares of 0.1p each

-Β 

1,361,935,975Β 

-Β 

1,361,936Β 

Deferred shares of 0.1p each

942,462,000Β 

942,462,000Β 

942,462Β 

942,462Β 

Deferred shares of Β£24 each

54,477Β 

-Β 

1,307,459Β 

-Β 

═══════════

═══════════

─────────

─────────

2,657,234Β 

2,304,398Β 

═════════

═════════

In April 2015, the Company carried out a capital reorganisation whereby the existing ordinary share capital was consolidated by the issue of 1 Consolidation Share of Β£25 each for every 25,000 existing ordinary shares of 0.1p each. The Consolidation Shares were then subdivided into 100 New Ordinary Shares of 1p each and 1 Deferred Share of Β£24 each

At the same time, the Company raised Β£1,076,150 through the issue of 35,283,591 New Ordinary Shares of 1p each to provide capital for the Company's Investing Policy. Β£50,000 of the funds raised were utilised in settlement of the unsecured Creditors in the Corporate Voluntary Arrangement that the Company entered into.

The deferred shares have no rights to vote, attend or speak at general meetings of the Company or to receive any dividend or other distribution and have limited rights to participate in any return of capital on a winding-up or liquidation of the Company.

Β 

Β 

Β 

21

Directors' emoluments

Key management personnel are those persons having authority and responsibility for planning, directing and controlling activities of the Group, including all directors of the Company.

2015

2014

Β£

Β£

Directors

Emoluments for qualifying services

126,659Β 

215,083Β 

Benefit in kind

2,975Β 

Equity-settled share based payment (note 19)

44,724Β 

-Β 

Pension contributions

7,125Β 

-Β 

───────

───────

181,483Β 

215,083Β 

═══════

═══════

Directors and key management personnel

2015

2014

Salaries and fees

Benefit in kind

Equity-settled share based payment

Pension

Total

Β£

Β£

Β£

Β£

Β£

Β£

Directors' emoluments

Edward Dawson

72,250Β 

2,975Β 

13,197Β 

7,125Β 

95,547Β 

-Β 

William Smith

8,500Β 

-Β 

10,509Β 

-Β 

19,009Β 

-Β 

Richard Mays

9,000Β 

-Β 

10,509Β 

-Β 

19,509Β 

-Β 

Gavin Burnell

8,576Β 

-Β 

10,509Β 

-Β 

19,085Β 

-Β 

Gerry Desler

10,000Β 

-Β 

-Β 

-Β 

10,000Β 

35,500Β 

Christian Schaffalitzky

3,333Β 

-Β 

-Β 

-Β 

3,333Β 

21,667Β 

Garth Earls

5,000Β 

-Β 

-Β 

-Β 

5,000Β 

52,500Β 

Richard Nolan

10,000Β 

-Β 

-Β 

-Β 

10,000Β 

60,000Β 

Colonel Robert Stewart

-Β 

-Β 

-Β 

-Β 

-Β 

20,416Β 

Dr Reza Tabrizi

-Β 

-Β 

-Β 

-Β 

-Β 

25,000Β 

───────

───────

───────

───────

───────

───────

126,659Β 

2,975Β 

44,724Β 

7,125Β 

181,483Β 

215,083Β 

═══════

═══════

═══════

═══════

═══════

═══════

The number of directors for whom retirement benefits are accruing under money purchase pension schemes amounted to 1 (2014 - 0).

Β 

22

Employees

Number of employees

There were 5 employees during the year including the directors (2014: 14).

Employment costs

2015

2014

Β£

Β£

Wages and salaries

211,659Β 

264,158Β 

Social security costs

20,186Β 

14,070Β 

Other pension costs

7,125Β 

-Β 

Equity settled share-based payments

70,993Β 

-Β 

───────

───────

309,963Β 

278,228Β 

═══════

═══════

23

Control

In the opinion of the directors, there is no ultimate controlling party.

24

Related party transactions

During the year there were consultancy fees and property related expenses of Β£nil (2014: Β£39,521) charged by Eurasia Mining Plc and included in trade payables at the year end is Β£nil (2014: Β£38,081) owing to Eurasia Mining Plc. Christian Schaffalitzky is a director of Eurasia Mining Plc.

Β 

During the year, there were consultancy fees of Β£17,200 (2014: Β£nil) charged by Sallork Legal and Commercial Consulting Limited ("Sallork") and included in trade payables at the year end is Β£1,200 (2014: Β£nil) owing to Sallork. Richard Mays is a director and shareholder of Sallork.

Included in trade and other payables are the following balances due to Directors as at 31 December 2015.

2015

2014

Β£

Β£

Christian Schaffalitzky

-Β 

13,333Β 

Garth Earls

-Β 

36,119Β 

Gerry Desler

-Β 

25,423Β 

Richard Nolan

-Β 

36,722Β 

═══════

═══════

In the Company's own accounts, full provision has been made against balances due from Central Asia Resources Limited and Premier Asia Resources LLC amounting to Β£nil (2014: Β£772,715) and Β£nil (2014: Β£689,546) respectively.

Β 

25

Subsequent events

Investment in Hutton Poland

in April 2016, PXOG County Limited ("PXOG"), the Company's wholly owned subsidiary, completed its acquisition of 210,700 ordinary shares and 588,000 Β£1 loan notes of Hutton Poland Limited ("Hutton Poland") for a total consideration of Β£620,000, being 49% of the issued share capital of Hutton Poland and its loan notes outstanding at completion, from Hutton Energy Limited ("Hutton"). the remaining 51% of the ordinary shares and loan notes are owned by Hutton.

Β 

Hutton has been active in Poland since 2009, holding various stakes in exploration licenses, and in the process has gathered a geologic and geophysical data set. Hutton Poland presently has seven license applications in process. The most advanced is the Kolo License application which was recently offered to Hutton Poland by the regulatory authorities.

Β 

The Kolo license was formally awarded in late April 2016.

The Kolo License area is located in the Lodz Trough within the Polish Central Lowlands, c120 km west of Warsaw. The directors of Prospex believe the region is well serviced by oil and gas surface facilities and sits on major European transport arteries. The Kolo License area is 1,150 square kilometres and is elongated in a NW-SE direction along the strike of the Lodz Trough, a well-known Mesozoic sedimentary basin. This basin is known in Poland by its salt mines (Klodava) but also by important manifestations of gas and oil in shallow water wells.

Hutton has 1400km of vintage 2D seismic data over the license area and gathered a further 250km of 2D seismic data in 2014. Recent geological studies and interpretation of geophysical data by Prospex have indicated that the Lodz Trough has the potential to contain commercial oil and gas accumulations at deeper and shallow levels in early and late Cretaceous sedimentary reservoir rocks, similarly to hydrocarbon provinces like the North Sea and the Baltic region.

Prospex believes the prospectivity of the license is in conventional targets as opposed to unconventional regional plays. In particular Prospex, from the data, has identified a number of conventional oil and gas exploration targets, between 1,000 and 4,000 metres below surface.

The Company has been advised by the directors of Hutton Poland that the Boleshaw prospect on the Kolo Licence is ready for drilling, with a drill location determined and a target spud date in the fourth quarter of 2016. The Boleshaw prospect has been worked up using 1650km of 2D seismic already owned by Hutton. Although timing is subject to a number of factors including environmental permitting and confirmation of a suitable rig.

In May 2016, Prospex received a Competent Persons Report which reviews the Kolo Licence from both a geological and economic perspective. A copy of the report is located on the Company's website: www.prospexoilandgas.com.

The Competent Persons Report's Key Points:

- Gross Best Estimate Technical Unrisked Prospective Resources for the Boleslaw prospect (within the Kolo Licence) are estimated at 87.1 Bscf. The indicative NPV ranges from $44m to $95m (net to Prospex).

- Economic assessments clearly indicated that in the case of a gas discovery with N2 content less than 50mol% a Gas-to-Power (combined heat and power, "CHP") development concept would be economically robust above a minimum threshold of around 25Bscf GIIP of gas.

- The notional CHP development scenarios were based on a single well assuming production rates of 20MMscf to 40MMscf per day (3333 to 6666 boe/d).

- The economic assessment based on the AGR TRACS N2 risk profile indicated a risked EMV of Β£5.0mln (net to Prospex), while corresponding evaluations assuming Prospex's N2 risk profile suggested a risked EMV of Β£8.4mln (net to Prospex), where both estimates were derived assuming current electricity prices.

Loan

25

Subsequent events

(continued)

Β 

Β 

On completion of the purchase of Hutton Poland PXOG entered into a loan agreement with Hutton to borrow Β£490,000. The loan is interest bearing from the date of the Kolo License award at LIBOR plus 2%. The loan and interest accrued are repayable on the latter of 31 August 2016 or 90 days after the unconditional award of the Kolo License. The loan is secured against PXOG's shares and loan notes in Hutton Poland. Hutton's recourse in default is limited to PXOG's shares and loans note in Hutton Poland.

Β 

Β 

Further investments

Β 

In addition to the Hutton Poland investment detailed above, the company made 3 additional investments: Elephant Oil Limited, MOL Hungarian Oil and Gas Public Limited Company and OMV Aktiengesellschaft. The directors believe these additional investments give the portfolio some further diversity providing exposure to a wider range of market capitalisations, up and downstream activities, and geopolitical risks.

Β 

Β 

In April 2016, the Company acquired 587,120 new Ordinary Shares in Elephant Oil Limited ("Elephant") for a consideration of Β£100,000. It now holds a 2.54% interest in Elephant..

Β 

Β 

In April 2016, the Company acquired 1,100 ordinary shares in MOL Hungarian Oil and Gas Public Limited Company ("MOL") for a consideration of $67,714 through the market. MOL is the parent company of the MOL group an integrated group of Oil and Gas companies headquartered in Hungary.

Β 

Β 

The Company has acquired 2,300 Ordinary Shares in OMV Aktiengesellschaft ("OMV") for a consideration of €55,418, through the market. OMV is the parent company of the OMV group, an integrated group of Oil and Gas companies headquartered in Austria.

Β 

Β 

Placing

Β 

In May 2016, the Company completed a placing to raise approximately Β£1.64 million from the issue of 164,600,000 new ordinary shares of 1p each ("New Ordinary Shares") at a price of 1p per share (the "Placing"), through WH Ireland Limited, Beaufort Securities Limited and Peterhouse Corporate Finance Limited. Dealings are expected to commence on 10 June 2016. The funds raised will be used to:

Β 

Β 

- Support the 2016 activities of Hutton Poland Limited;

Β 

- Repay the loan from Hutton Energy Limited (see above); and

Β 

- For general working capital purposes.

Β 

Β 

Investing Policy

Β 

On 13 April 2016 announced that it had implemented its original Investment Policy adopted on 14 April 2015.

Β 

Β 

On 11 May 2016 the shareholders, at a general meeting, gave approval to the existing investing policy with an amendment. The full investing policy is set out below, with the approved amendment shown in the final paragraph.

Β 

Β 

The Company's Investing Policy is to invest in and/or acquire companies and/or projects within the natural resources and/or energy sector with potential for growth and/or income. The Company may also directly apply for new exploration licences or invest in existing licences. It is anticipated that the geographical focus will primarily be Europe, however, investments may also be considered in other regions to the extent that the Directors consider that valuable opportunities exist and returns can be achieved.

Β 

Β 

In selecting investment opportunities, the Directors will focus on businesses, assets and/or projects that are available at attractive valuations and hold opportunities to unlock embedded value. Where appropriate, the Directors may seek to invest in businesses where it may influence the business at a board level, add their expertise to the management of the business, and utilise their significant industry relationships and access to finance; as such investments are likely to be actively managed.

Β 

Β 

The Company's interests in a proposed investment and/or acquisition may range from a minority position to full ownership and may comprise one investment or multiple investments.The proposed investments may be in either quoted or unquoted companies; be made by direct applications, acquisitions or farm-ins; and may be in companies, partnerships, earn-in joint ventures, debt or other loan structures or direct or indirect interests in assets, projects or licences. The Directors may focus on investments where intrinsic value can be achieved from the restructuring of investments or merger of complementary businesses.

Β 

The Directors expect that investments will typically be held for the medium to long term, although short term disposal of assets cannot be ruled out if there is an opportunity to generate an attractive return for Shareholders. The Directors will place no minimum or maximum limit on the length of time that any investment may be held.

Β 

Β 

There is no limit on the number of projects into which the Company may invest, and the Company's financial resources may be invested in a number of propositions or in just one investment, which may be deemed to be a reverse takeover under the AIM Rules. The Directors intend to mitigate risk by appropriate due diligence and transaction analysis. Any transaction constituting a reverse takeover under the AIM Rules will also require Shareholders' approval. The Directors consider that as investments are made, and new promising investment opportunities arise, further funding of the Company may also be required.

Β 

Β 

Where the Company builds a portfolio of related assets it is possible that there may be cross holdings between such assets. The Company does not currently intend to fund any investments with debt or other borrowings but may do so if appropriate. Investments in early stage assets are expected to be mainly in the form of equity, with debt potentially being raised later to fund the development of such assets. Investments in later stage assets are more likely to include an element of debt to equity gearing. The Directors may also offer new Ordinary Shares by way of consideration as well as cash, thereby helping to preserve the Company's cash for working capital and as a reserve against unforeseen contingencies including, for example, delays in collecting accounts receivable, unexpected changes in the economic environment and operational problems.

Β 

Β 

The Directors will conduct initial due diligence appraisals of potential business or projects and, where they believe further investigation is warranted, intend to appoint appropriately qualified persons to assist. The Directors believe they have a broad range of contacts through which they are aware of various opportunities which may prove suitable, although at this point only preliminary due diligence has been undertaken. The Directors believe their expertise will enable them to determine quickly which opportunities could be viable and so progress quickly to formal due diligence. The Company will not have a separate investment manager. The Company proposes to carry out a comprehensive and thorough project review process in which all material aspects of a potential project or business will be subject to rigorous due diligence, as appropriate. Due to the nature of the sector in which the Company is focused it is unlikely that cash returns will be made in the short to medium term; rather the Company expects a focus on capital returns over the medium to long term.

Β 

Β 

Amendment

Β 

The Company will undertake an acquisition or acquisitions within the natural resources and/or energy sector, which constitutes a reverse takeover under AIM Rule 14 of the AIM Rules for Companies within 12 months of the date of the general meeting.

Β 

Β 

Β 

26

Financial instruments

The principal financial instruments used by the Group, from which financial instrument risk arises are as follows

- Derivative financial assets

- Trade and other receivables

- Cash and cash equivalents

- Trade and other payables

A summary of the financial instruments held by category is provided below:

2015

2014

Financial assets

Β£

Β£

Loans and receivables

Trade and other receivables

155,909Β 

33,928Β 

Cash and cash equivalents

382,216Β 

22,734Β 

Derivative financial assets

-Β 

46,359Β 

─────────

─────────

Total financial assets

538,125Β 

103,021Β 

═════════

═════════

2015

2014

Financial liabilities

Β£

Β£

Trade and other payables

80,875Β 

845,657Β 

═════════

═════════

Fair value measurement

Level 1

Level 2

Level 3

Β£

Β£

Β£

Derivative financial assets

At 31 December 2015

-Β 

-Β 

-Β 

═════════

═════════

═════════

At 31 December 2014

-Β 

46,359Β 

-Β 

═════════

═════════

═════════

The Directors consider that the carrying amount of trade and other receivables and trade and other payables approximate their fair value.

Financial risk management

The Group's activities expose it to a variety of risks including market risk (foreign currency risk and interest rate risk), credit risk and liquidity risk. The Group manages these risks through an effective risk management programme and through this programme, the Board seeks to minimise potential adverse effects on the Group's financial performance.

The Board provides written objectives, policies and procedures with regards to managing currency and interest risk exposures, liquidity and credit risk including guidance on the use of certain derivative and non derivative financial instruments

Β 

Credit risk

Credit risk is the risk of financial loss to the Group if a customer or counterparty to a financial instrument fails to meet its contractual obligations. The Group's credit risk is primarily attributable to its receivables and its cash deposits. It is Group policy to assess the credit risk of new customers before entering contracts. The credit risk on liquid funds is limited because the counterparties are banks with high credit-ratings assigned by international credit-rating agencies.

Liquidity risk and interest rate risk

Liquidity risk arises from the Group's management of working capital. It is the risk that the Group will encounter difficulty in meeting its financial obligations as they fall due. The Board regularly receives cash flow projections for a minimum period of 12 months, together with information regarding cash balances monthly.

The Group is principally funded by equity and invests in short-term deposits, having access to these funds at short notice. The Group's policy throughout the period has been to minimise interest rate risk by placing funds in risk free cash deposits but also to maximise the return on funds placed on deposit.

All cash deposits attract a floating rate of interest. The benchmark rate for determining interest receivable and floating rate assets is linked to the UK base rate.

Foreign currency exposure

The Group had entities which operated in Kyrgyzstan and were therefore exposed to foreign exchange risk arising from currency exposure to the Kyrgyzstan Som, the functional currency of those subsidiaries. The overseas subsidiaries operated separate bank accounts which were used solely for those subsidiaries, thus managing the currency in that country. The Group's net assets arising from the overseas subsidiaries were exposed to currency risk resulting in gains or losses on retranslation into sterling. In April 2015, the Company disposed of these subsidiaries and since then, it is no longer exposed to this risk.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
FR AKCDNOBKDNAK
Date   Source Headline
27th Mar 20129:32 amRNSSchedule 1 update - Premier Management Holdings
15th Mar 20122:40 pmRNSReplacement:Proposed Acquisition & Notice of GM
13th Mar 20122:48 pmRNSProposed Acquisition & Notice of General Meeting
13th Mar 20122:34 pmRNSSch 1 - Premier Management Holdings Plc
14th Feb 20127:00 amRNSUpdate Re. Suspension and Acquisition
16th Nov 20117:30 amRNSSuspension - Premier Mgmt Hldgs Plc
16th Nov 20117:00 amRNSSuspension & Update Re Acquisition
26th Oct 201112:04 pmRNSHolding(s) in Company
26th Oct 201112:02 pmRNSHolding(s) in Company
20th Oct 20117:00 amRNSHalf Yearly Report
30th Sep 20117:00 amRNSTotal Voting Rights
19th Sep 20115:13 pmRNSAdditional Listing
13th Sep 20114:32 pmRNSHolding(s) in Company
4th Aug 201110:26 amRNSChange of Adviser
29th Jul 201110:19 amRNSResult of AGM
30th Jun 201110:13 amRNSTotal Voting Rights
28th Jun 201110:42 amRNSFinal Results
24th Jun 20119:41 amRNSHolding(s) in Company
31st May 20111:38 pmRNSTotal Voting Rights
25th May 20113:09 pmRNSIssue of Equity
11th May 20113:54 pmRNSAdditional Listing
31st Mar 20111:53 pmRNSTotal Voting Rights
21st Mar 20117:00 amRNSIssue of Equity
22nd Feb 20112:30 pmRNSAppointment of Broker
15th Nov 20105:33 pmRNSPDMR Shareholding
12th Nov 20103:02 pmRNSResult of GM & Board Changes
1st Nov 20104:12 pmRNSHolding(s) in Company
27th Oct 20107:00 amRNSOption to acquire Central Asia Resources
27th Oct 20107:00 amRNSOption to acquire Central Asia Resources
30th Jul 201012:41 pmRNSResult of AGM
6th Jul 20103:38 pmRNSPreliminary Results
9th Mar 201011:22 amRNSCancellation of Option Agreement
6th Jan 201012:42 pmRNSOption Agreement
31st Dec 20099:44 amRNSOption Agreement
26th Oct 200910:21 amRNSInterim Results
30th Sep 20098:42 amRNSOption Agreement
23rd Jul 200912:11 pmRNSOption Agreement
8th Jul 20099:57 amRNSPreliminary Results
30th Jun 20092:30 pmRNSOption Agreement
27th Oct 20087:00 amRNSInterim Results
29th Jul 20087:00 amRNSFinal Results
14th Feb 20083:18 pmRNSHolding(s) in Company
4th Feb 200811:17 amRNSIssue of Equity
8th Jan 200811:41 amRNSHolding(s) in Company
27th Dec 200711:30 amRNSTotal Voting Rights
20th Dec 200711:40 amRNSIssue of Equity
30th Oct 20077:00 amRNSInterim Results
23rd Aug 20074:06 pmRNSAIM Notice (26)
1st Aug 20073:43 pmRNSDirector/PDMR Shareholding
31st Jul 20077:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.